Supernus investors are running for the hills, but analyst sees elimination of 18 mg dose as a good move.
Investors to get a better viewpoint of Trulance during today’s call, says analyst.
Cantor analyst William Tanner is out today with a few insights on TherapeuticsMD Inc (NYSEMKT:TXMD), after the drug maker announced the publication of a manuscript …
Largely dismissing investor skepticism questioning the viability of TherapeuticsMD Inc (NYSEMKT:TXMD) vaginal soft gel capsule TX-004, analyst William Tanner of Cantor is confident …
Novavax, Inc. (NASDAQ:NVAX) shares were rising 5% in after-hours trading yesterday after the company reported second-quarter financials and provided investors with an update …
Cantor analyst William Tanner is out with a research note on shares of TherapeuticsMD Inc (NYSEMKT:TXMD), after the company provided an update regarding the New Drug Application …
In a research report released Thursday, Cantor analyst William Tanner initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with an Overweight rating and price target …
Novavax, Inc. (NASDAQ:NVAX) shares fell almost 10% in after-market hours on the heels of the firm’s release of fourth-quarter financials and clinical updates.
Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) stock is on a 9% rise after receiving abbreviated new drug application (ANDA) approval as well …
Cantor analyst William Tanner remains sidelined on shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) amid their nearly 36% crash yesterday.